Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis

Tuberculosis

Volumn 94, Issue 1, 2014, Pages 55-64

  Marzo, Elena ^a   Vilaplana, Cristina ^a   Tapia, Gustavo ^a   Diaz, Jorge ^a   Garcia, Vanessa ^a   Cardona, Pere Joan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Active tuberculosis; C3HeB FeJ mice; Experimental murine model of tuberculosis; Kramnik mouse model; Liquefaction; Neutrophils

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; IBUPROFEN; ICOSANOID; INTERLEUKIN 17; INTERLEUKIN 6; LEUKOTRIENE B4; LIPOXIN A; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CELL DESTRUCTION; CELL WALL; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GRANULOMA; HISTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; INFECTION RESISTANCE; LUNG ALVEOLUS CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; ROLE PLAYING; SURVIVAL; TISSUE NECROSIS; TUBERCULOSIS; TUMOR GROWTH;

ACTIVE TUBERCULOSIS; C3HEB/FEJ MICE; EXPERIMENTAL MURINE MODEL OF TUBERCULOSIS; KRAMNIK MOUSE MODEL; LIQUEFACTION; NEUTROPHILS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CHEMOKINE CXCL5; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GRANULOMA; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKIN-6; MICE; MICE, INBRED C3H; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL INFILTRATION; NEUTROPHILS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891555267     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.09.004     Document Type: Article

References (46)

1. P.J. Cardona A dynamic reinfection hypothesis of latent tuberculosis infection Infection 37 2009 80 86 10.1007/s15010-008-8087-y
2. O. Gil, I. Diaz, C. Vilaplana, G. Tapia, J. Diaz, M. Fort, N. Caceres, S. Pinto, J. Cayla, L. Corner, M. Domingo, and P.J. Cardona Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs PLoS One 5 4 2010 Apr 6 e10030 10.1371/journalpone0010030
3. A. Casadevall, and L.A. Pirofski The damage-response framework of microbial pathogenesis Nat Rev Microbiol 1 2003 17 24
4. Cardona PJ. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch Immunol Ther Exp (Warsz);58:7-14. http://dx.doi.org/10.1007/ s00005-009-0062-5.
5. J. Grosset Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary Antimicrob Agents Chemother 47 2003 833 836 (Pubitemid 36254203)
6. E. Guirado, I. Amat, O. Gil, J. Diaz, V. Arcos, N. Caceres, V. Ausina, and P.J. Cardona Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice Microbes Infect 8 2006 1252 1259 (Pubitemid 43831690)
7. E.R. Driver, G.J. Ryan, D.R. Hoff, S.M. Irwin, R.J. Basaraba, I. Kramnik, and A.J. Lenaerts Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis Antimicrob Agents Chemother 56 2012 3181 3195 10.1128/AAC.00217-12
8. B.S. Yan, A. Kirby, Y.V. Shebzukhov, M.J. Daly, and I. Kramnik Genetic architecture of tuberculosis resistance in a mouse model of infection Genes Immun 7 3 2006 Apr 201 210
9. A.A. Chackerian, T.V. Perera, and S.M. Behar Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis Infect Immun 69 2001 2666 2674 10.1128/iai.69.4.2666- 2674 (Pubitemid 32239743)
10. H. Pan, B.S. Yan, M. Rojas, Y.V. Shebzukhov, H. Zhou, L. Kobzik, D.E. Higgins, M.J. Daly, B.R. Bloom, and I. Kramnik Ipr1 gene mediates innate immunity to tuberculosis Nature 434 2005 767 772 10.1038/nature03419 (Pubitemid 44739520)
11. J. Sissons, B.S. Yan, A.V. Pichugin, A. Kirby, M.J. Daly, and I. Kramnik Multigenic control of tuberculosis resistance: analysis of a QTL on mouse chromosome 7 and its synergism with sst1 Genes Immun 10 1 2009 Jan 37 46 10.1038/gene200868 [Epub 2008 Sep 11]
12. A.B. Kamath, J. Alt, H. Debbabi, and S.M. Behar Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis Infect Immun 71 2003 4112 4118 (Pubitemid 36753740)
13. J. Harper, C. Skerry, S.L. Davis, R. Tasneen, M. Weir, I. Kramnik, W.R. Bishai, M.G. Pomper, E.L. Nuermberger, and S.K. Jain Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions J Infect Dis 205 2012 595 602
14. I.M. Rosenthal, R. Tasneen, C.A. Peloquin, M. Zhang, D. Almeida, K.E. Mdluli, P.C. Karakousis, J.H. Grosset, and E.L. Nuermberger Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis Antimicrob Agents Chemother 56 2012 4331 4340
15. C. Skerry, J. Harper, M. Klunk, W.R. Bishai, and S.K. Jain Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas PLoS One 7 2012 e39680 10.1371/journal.pone. 0039680
16. S.L. Davis, E.L. Nuermberger, P.K. Um, C. Vidal, B. Jedynak, M.G. Pomper, W.R. Bishai, and S.K. Jain Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment Antimicrob Agents Chemother 53 2009 4879 4884 10.1128/AAC.00789-09
17. C. Vilaplana, E. Marzo, G. Tapia, J. Diaz, V. Garcia, and P.J. Cardona Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis J Infect Dis 208 2 2013 Jul 199 202 10.1093/infdis/jit152 [Epub 2013 Apr 5]
18. Prophet EB, Mills B, Arrington JB, Sobin LH, (eds). Laboratory methods in histotechnology (Armed Forces Institute of pathology). In: Prophet EB, Mills B, Arrington JB, Sobin LH, editors. Laboratory methods in histotechnology (Armed Forces Institute of Pathology). Washington, DC: American Registry of Pathology, Armed Forces Institute of Pathology; 1992. p. 1.
19. R. Grenville-Mathers Cavitation in pulmonary tuberculosis Tubercle 28 1947 139 143
20. P.-J. Cardona A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis Clin Dev Immunol 2011 2011 868246 10.1155/2011/868246
21. P. Elkington, T. Shiomi, R. Breen, R.K. Nuttall, C.A. Ugarte-Gil, N.F. Walker, L. Saraiva, B. Pedersen, F. Mauri, M. Lipman, D.R. Edwards, B.D. Robertson, J. D'Armiento, and J.S. Friedland MMP-1 drives immunopathology in human tuberculosis and transgenic mice J Clin Invest 121 2011 1827 1833 10.1172/JCI45666
22. A.G. Cheng, A.C. DeDent, O. Schneewind, and D. Missiakas A play in four acts: Staphylococcus aureus abscess formation Trends Microbiol 19 2011 225 232 10.1016/j.tim.2011.01.007
23. R.A. Brown, R. Lever, N.A. Jones, and C.P. Page Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro Br J Pharmacol 139 2003 845 853 10.1038/sj.bjp.0705291 (Pubitemid 36819612)
24. D.M. Lowe, P.S. Redford, R.J. Wilkinson, A. O'Garra, and A.R. Martineau Neutrophils in tuberculosis: friend or foe? Trends Immunol 33 2012 14 25 10.1016/j.it.2011.10.003
25. R.W. Glenny, and H.T. Robertson Determinants of pulmonary blood flow distribution Comprehensive physiology vol. 1 2010 John Wiley & Sons, Inc 39 59
26. G. Canetti The tubercle bacillus in the pulmonary lesion of man Histobacteriology and its bearing on the therapy of pulmonary tuberculosis 1955 Springer Publishing Company, Inc New York
27. H.B. Kaplan, H.S. Edelson, H.M. Korchak, W.P. Given, S. Abramson, and G. Weissmann Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo Biochem Pharmacol 33 3 1984 Feb 1 371 378 (Pubitemid 14163156)
28. S. Abramson, H. Edelson, H. Kaplan, R. Ludewig, and G. Weissmann Inhibition of neutrophil activation by nonsteroidal anti-inflammatory drugs Am J Med 77 4B 1984 Oct 15 3 6 (Pubitemid 15207523)
29. L.E. Rovai, H.R. Herschman, and J.B. Smith The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia J Leukoc Biol 64 1998 494 502 (Pubitemid 28455395)
30. V. Brinkmann, and A. Zychlinsky Beneficial suicide: why neutrophils die to make NETs Nat Rev Microbiol 5 8 2007 Aug 577 582 (Pubitemid 47074113)
31. T.A. Fuchs, U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y. Weinrauch, V. Brinkmann, and A. Zychlinsky Novel cell death program leads to neutrophil extracellular traps J Cell Biol 176 2 2007 Jan 15 231 241 [Epub 2007 Jan 8] (Pubitemid 46143263)
32. D. Ermert, C.F. Urban, B. Laube, C. Goosmann, A. Zychlinsky, and V. Brinkmann Mouse neutrophil extracellular traps in microbial infections J Innate Immun 1 3 2009 181 193 10.1159/000205281 [Epub 2009 Feb 26]
33. T. Narasaraju, E. Yang, R.P. Samy, H.H. Ng, W.P. Poh, A.A. Liew, M.C. Phoon, N. van Rooijen, and V.T. Chow Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis Am J Pathol 179 1 2011 Jul 199 210 10.1016/jajpath201103013 [Epub 2011 May 7]
34. A. Caudrillier, K. Kessenbrock, B.M. Gilliss, J.X. Nguyen, M.B. Marques, M. Monestier, P. Toy, Z. Werb, and M.R. Looney Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury J Clin Invest 122 7 2012 Jul 2 2661 2671 10.1172/JCI61303 [Epub 2012 Jun 11]
35. V. Ramos-Kichik, R. Mondragon-Flores, M. Mondragon-Castelan, S. Gonzalez-Pozos, S. Muniz-Hernandez, O. Rojas-Espinosa, R. Chacon-Salinas, S. Estrada-Parra, and I. Estrada-Garcia Neutrophil extracellular traps are induced by Mycobacterium tuberculosis Tuberculosis (Edinb) 89 1 2009 Jan 29 37 10.1016/jtube200809009 [Epub 2008 Dec 3]
36. J.J. Bates, R.W. Watson, C.M. Glynn, A.J. O'Neill, J.M. Fitzpatrick, and D.J. Buggy Aspirin preserves neutrophil apoptosis after cardiopulmonary bypass Shock 21 6 2004 Jun 495 499
37. R.C. Gillis, B.J. Daley, B.L. Enderson, D.P. Kestler, and M.D. Karlstad Regulation of apoptosis in eicosapentaenoic acid-treated HL-60 cells J Surg Res 137 1 2007 Jan 141 150 [Epub 2006 Nov 3] (Pubitemid 44879437)
38. S. Negrotto, E. Malaver, M.E. Alvarez, N. Pacienza, L.P. D'Atri, R.G. Pozner, R.M. Gómez, and M. Schattner Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli J Pharmacol Exp Ther 319 2 2006 Nov 972 979 [Epub 2006 Aug]
39. R. Blomgran, L. Desvignes, V. Briken, and J.D. Ernst Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells Cell Host Microbe 11 1 2012 Jan 19 81 90 10.1016/ jchom201111012
40. R. Blomgran, and J.D. Ernst Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection J Immunol 186 12 2011 Jun 15 7110 7119 10.4049/jimmunol1100001 [Epub 2011 May 9]
41. M. Hachicha, M. Pouliot, N.A. Petasis, and C.N. Serhan Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis J Exp Med 189 12 1999 Jun 21 1923 1930
42. S. Mitchell, G. Thomas, K. Harvey, D. Cottell, K. Reville, G. Berlasconi, N.A. Petasis, L. Erwig, A.J. Rees, J. Savill, H.R. Brady, and C. Godson Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J Am Soc Nephrol 13 10 2002 Oct 2497 2507
43. M. Chen, M. Divangahi, H. Gan, D.S. Shin, S. Hong, D.M. Lee, C.N. Serhan, S.M. Behar, and H.G. Remold Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death J Exp Med 205 12 2008 Nov 24 2791 2801 10.1084/jem20080767 [Epub 2008 Oct 27]
44. M. Divangahi, D. Desjardins, C. Nunes-Alves, H.G. Remold, and S.M. Behar Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis Nat Immunol 11 8 2010 Aug 751 758 10.1038/ni1904 [Epub 2010 Jul 11]
45. D.M. Tobin, F.J. Roca, S.F. Oh, R. McFarland, T.W. Vickery, J.P. Ray, D.C. Ko, Y. Zou, N.D. Bang, T.T. Chau, J.C. Vary, T.R. Hawn, S.J. Dunstan, J.J. Farrar, G.E. Thwaites, M.C. King, C.N. Serhan, and L. Ramakrishnan Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections Cell 148 3 2012 Feb 3 434 446 10.1016/jcell201112023
46. J. Ivanyi, and A. Zumla Nonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment J Infect Dis 208 2 2013 Jul 185 188 10.1093/infdis/jit153 [Epub 2013 Apr]